Testing effectiveness (Phase 2)Study completedNCT03012672
What this trial is testing
Higher or Lower Dose Cladribine, Cytarabine, and Mitoxantrone in Treating Medically Less Fit Patients With Newly Diagnosed Acute Myeloid Leukemia or Myeloid Neoplasm
Who this might be right for
Acute Leukemia of Ambiguous LineageAcute Myeloid LeukemiaMyeloid Neoplasm
University of Washington 50